The global vacuum blood collection tube market size was valued at USD 2.98 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.02% from 2023 to 2030. Vacuum blood collection tubes are also known as vacutainers. The tube comprises a plastic adapter attached to a double-pointed needle. Vacutainers are used to protect against needle injuries and contamination from human touch. These tubes are user-friendly, and versatile, and produce high-quality specimens. In addition, the main advantages of these tubes include accurate scale readings and they are environmentally friendly. The COVID-19 pandemic has increased the demand for rapid testing methods and vacuum blood collection tubes for disease surveillance and management of outbreaks.
Moreover, there has been an upsurge in the development of cost-effective, portable, and easy-to-use vacutainers for supporting diagnostic testing activities. For instance, in July 2021, BD’s vacutainer received Emergency Use Authorization (EUA) from FDA for its BD Vacutainer Plus Citrate Plasma Tubes. These tubes are used to test coagulopathy for COVID-19 hospitalized patients; such approvals led to short supply because of the increased demand during the public health emergency. Hence, the COVID-19 pandemic has positively affected the growth of the market. The increasing incidence of chronic diseases, such as various infectious diseases and non-infectious diseases (including diabetes, cardiovascular diseases, & cancer), is a major factor driving the growth of the industry.
Various factors, such as unhealthy & sedentary lifestyles, alcohol abuse, smoking, and antimicrobial resistance, are contributing to the rising prevalence of these diseases. As per the data from the IDF Diabetes Atlas, there were about 537 million adults living with diabetes in 2021, and this number is anticipated to increase to 643 million by 2030. The disease is estimated to have caused 6.7 million deaths in 2021. Thus, the increasing prevalence of diabetes is boosting the demand for vacutainers for performing recurring diagnostic tests, such as blood sugar assays. Furthermore, the rising number of accidents and injuries will propel the demand for blood transfusion during the assessment period.
Trauma patients or accident causalities often face blood loss. Thus, blood transfusion is required to restore the lost volume. Therefore, the increasing incidence of injuries coupled with the rising demand for transfusion in trauma patients globally is anticipated to drive industry growth during the projected period. For instance, according to the WHO, about 118.5 million blood donations are collected globally each year. Hence, there is an increase in pre-transfusion blood tests to avoid Transfusion-Transmitted Infections (TTIs) and ensure the safety of the patients, thus fueling the industry's growth.
Moreover, the growing incidence of hematological disorders is likely to fuel the market during the forecast period. Hematologic diseases include anemia, sickle cell disease, bleeding disorders, such as clots, hemophilia, and cancers, such as myeloma, lymphoma, and leukemia. For instance, according to the Leukemia & Lymphoma Society, every three minutes, approximately, one person is diagnosed with blood cancer. In addition, according to the WHO, globally, 40% of pregnant women and 42% of children below five years of age are anemic. Thus, the increasing prevalence of hematological disorders requires vacutainers for the diagnosis of the disorders, thereby propelling industry growth.
The serum separation tubes segment accounted for the largest share of 25.00% in 2022. This is attributed to the advantages associated with separation tubes, such as rapid separation of serum from cellular components of blood, eliminating the need for aliquoting serum, reducing the aerosolization of hazardous substances, decreasing the pre-analytical turnaround time, and enabling easy transportation. For instance, the serum for certain analytes, such as glucose, phosphorus, and potassium, must be separated within a few hours; otherwise, the results will be significantly distorted. Using a serum-separating tube, such as the BD SST II Advance tube, maintains the stability of the routine analytes in the laboratory for up to a week at a storage temperature of 2-8ºC.
The EDTA tubes segment is projected to grow at the fastest CAGR over the forecast period. EDTA is the typical anticoagulant used in blood collection tubes.It inhibits clotting by chelating or removing calcium from the blood and prevents the distortion of cells, making it ideal for most hematological tests. Thus, EDTA vacutainers are used in immunohematology, whole blood determination, or for the molecular biological identification of bacteria, parasites, and viruses, after centrifugation and plasma for clinical chemistry. Such capabilities are likely to boost segment growth over the forecast period.
On the basis of materials, the global industry has been further categorized into PET/plastic and glass. The PET/plastic material segment dominated the industry in 2022 and accounted for the maximum share of more than 88.5% of the overall revenue. The high share of this segment can be attributed to the significant advantages offered by plastic tubes, such as reduced exposure to biohazardous material following breakage, better endurance to higher centrifugation speeds, increased shock resistance, lower weight, and ease of disposal through incineration at a lower cost.
The PET/plastic material segment is anticipated to expand further at the fastest growth rate retaining its dominant position in the industry throughout the forecast years. This can be attributed to the long-term storage of samples enabled by PET/plastic tubes. For instance, freshly drawn blood samples can be stored for more than 12 months in commercially available PET/plastic. These qualities of PET/plastic are expected to drive the segment during the forecast period.
The blood routine examination segment accounted for the largest share of more than 24.20% in 2022. This can be attributed to the broad range of applications of vacutainers in disease diagnosis. Blood routine examinations are used to measure cells, proteins, chemicals, and other substances in the blood. These tests help in monitoring a chronic condition or disease, such as high cholesterol or diabetes, identify if treatment for a disease is working, check how well organs including the liver, heart, thyroid, and kidneys are functioning, and analyze if the individual’s immune system is having any trouble fighting infections. Furthermore, results of these examinations can be obtained in a few minutes to hours, which helps start immediate treatment in severe cases. Thus, such applications drive the adoption of vacutainers for disease diagnosis.
The coagulation tests segment is expected to expand at the fastest CAGR from 2023 to 2030. Coagulation tests are used in monitoring patients who take medications that affect their clotting ability including cancer, vitamin K deficiency, liver disease, venom from a snakebite, blood transfusions, and inability to absorb fat, among others. For instance, according to the WHO, cancer was a leading cause of death globally in 2020 and accounted for 10 million deaths. In addition, these tests are usually performed before surgery, with persistent swelling, blood clots, unexplained pain, and stiffness. Furthermore, they help in understanding the impact of hereditary disorders, such as Hemophilia A and Hemophilia B. All these factors are likely to aid revenue generation in this segment.
The pathology laboratories segment dominated the industry in 2022 and accounted for the highest share of 44.38% of the overall revenue due to the high prevalence of various diseases, such as hepatitis B, HIV AIDS, diabetes, cancer, and heart diseases, which require various blood tests to confirm the extremity of the disease. For instance, according to the UNAIDS in 2021 approximately 1.5 million people were newly infected with HIV. Thus, pathology laboratories require vacutainers to perform several tests, thereby fueling segment growth.
Furthermore, the pathology laboratories segment is expected to register the fastest growth rate during the forecast period. The advantages associated with the vacutainers, such as they provide precise results, high-quality, and reliable blood collection facilitates testing of various types of samples. Increasing inclination toward pathology laboratories for gaining fast and cost-effective testing services is expected to be a primary factor driving the demand for vacuum blood collection tubes, thus boosting segment growth.
North America held the largest share of more than 37.25% of the overall revenue in 2022 due to the existence of sophisticated healthcare infrastructure, prominent vacutainer suppliers, and strong government support. According to the American Red Cross, someone in the United States requires platelets or blood every two seconds. This rising need for blood in North American economies is attributed to a large share of the market. Furthermore, increased infectious disease testing and high demand for blood examination in the region due to the COVID-19 pandemic have positively affected the market growth.
The Asia Pacific region is projected to register the fastest CAGR from 2023 to 2030 due to the growing population in countries, such as China and India, coupled with the increasing epidemic of infectious diseases. Moreover, the rising prevalence of chronic diseases, such as cancer and cardiovascular diseases, is another factor contributing to the region’s growth. Growing awareness regarding blood donation and safe transfusion procedures, due to favorable government and private campaigns, will further enhance the growth potential of this region during the forecast period.
The industry is growing at a rapid pace due to the various strategic initiatives adopted by key companies. For instance, in June 2021, Sekisui Medical acquired Veredus Laboratories. Pte. Ltd. This acquisition helped the company in enhancing its stake in the Asian industry. Key companies operating in the global vacuum blood collection tube market include:
Advin Health Care
Hindustan Syringes & Medical Devices
MB Plastic Industries
Market size value in 2023
USD 2.60 billion
Revenue forecast in 2030
USD 3.20 billion
CAGR of 3.02% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million/billion and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Type, material, application, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
SEKISUI CHEMICAL; BD; Cardinal Health; Greiner AG; InterVacTechnology; Advin Health Care; AdvaCare Pharma; Hindustan Syringes & Medical Devices; MB Plastic Industries; Biota
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs.Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global vacuum blood collection tube market report based on type, material, application, end-use, and regions:
Type Outlook (Revenue, USD Million, 2018 - 2030)
Serum Separating Tubes
Plasma Separation Tubes
Rapid Serum Tubes
Material Outlook (Revenue, USD Million, 2018 - 2030)
Application Outlook (Revenue, USD Million, 2018 - 2030)
Serology & Immunology
Blood Routine Examination
Blood Sugar Assay
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Clinics
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East and Africa (MEA)
b. The global vacuum blood collection tubes market size was estimated at USD 2.98 billion in 2022 and is expected to reach USD 2.60 billion in 2023.
b. The global vacuum blood collection tubes market is expected to grow at a compound annual growth rate of 3.02% from 2023 to 2030 to reach USD 3.20 billion by 2030.
b. The serum separation tubes segment dominated the global market in 2022 and captured the maximum share of the overall revenue. The large share can be attributed to the advantages associated with separation tubes such as the rapid separation of serum from cellular components of blood, eliminates of the need for aliquotting serum, reduces the aerosolization of hazardous substances, decreases the pre-analytical turnaround time, and enables easy transportation.
b. Some key players operating in the vacuum blood collection tubes market include SEKISUI CHEMICAL, BD, Cardinal Health, Greiner AG, InterVacTechnology, Advin Health Care, AdvaCare Pharma, Hindustan Syringes & Medical Devices, MB Plastic Industries and Biota.
b. The increasing incidence of chronic diseases such as various infectious diseases and non-infectious diseases (including diabetes, cardiovascular diseases, & cancer) is a major factor driving the growth of the vacuum blood collection tubes market globally. Furthermore, the rising number of accidents and injuries will propel the demand for blood transfusion during the study period.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."